Skip to content
Naratuximab emtansine
Naratuximab emtansine is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against leukocyte antigen CD37.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
2 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-hodgkin lymphomaD008228C85.911———2
Large b-cell lymphoma diffuseD016403C83.3—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
B-cell chronic lymphocytic leukemiaD015451C91.11————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameNARATUXIMAB EMTANSINE
INNnaratuximab emtansine
Description
IMGN-529 (mab)
Classification
Antibody
Drug classmonoclonal antibodies; maytansinoid derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL2109268
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDWE1X5A83B9 (ChemIDplus, GSRS)
Target
Agency Approved
CD37
CD37
Organism
Homo sapiens
Gene name
CD37
Gene synonyms
TSPAN26
NCBI Gene ID
951
Protein name
leukocyte antigen CD37
Protein synonyms
CD37, cell differentiation antigen 37, leukocyte surface antigen CD37, Tetraspanin-26, Tspan-26
Uniprot ID
P11049
Mouse ortholog
Cd37 (12493)
leukocyte antigen CD37 (Q61470)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 24 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details